Skila Expands Global Partnership With Boehringer Ingelheim Corporation

MORRIS PLAINS, N.J., July 27 /PRNewswire/ -- Skila, a Sela2 Company, has expanded its existing partnership with Boehringer Ingelheim GmbH to provide knowledge management solutions to support the pharmaceutical company's sales and marketing effectiveness.

Skila has been a longstanding partner of Boehringer Ingelheim in providing knowledge management solutions in the areas of launch management, alliance management, competitive intelligence, performance management, and thought leader management.

Under the terms of this contract expansion, Boehringer will implement Skila's comprehensive suite of solutions as its Brand Resource Platform serving products in various stages across Boehringer Ingelheim's brand portfolio in prescription medicine and consumer health. With an installed base extending from Boehringer Ingelheim corporate headquarters in Ingelheim, Germany, to affiliates in numerous countries worldwide, Skila's platform will allow Boehringer Ingelheim to improve communication, increase coordination, and enhance planning and decision-making capabilities across the global organization.

"The value of Skila's solutions is exponentially enhanced when integrated on a global scale. We are pleased to be building upon our partnership with Boehringer to streamline their marketing process at all levels of their organization," said Moish Tov, CEO of Skila.

About Skila

Skila is a customer-driven company and a leader in developing best-in-class knowledge-driven management solutions for the pharmaceutical industry. Skila's solutions help the pharmaceutical industry increase their marketing and brand effectiveness and have been adopted by many of the leading companies in the industry, such as: Boehringer Ingelheim, Roche, Eli Lilly & Company, Allergan, and Johnson & Johnson. Utilizing expert services, unique methodology and its Intelligration(R) technology, Skila's solutions integrate critical information communicating it to the right people, at the right time through a "Single Touch Point." These solutions are vital to pharmaceutical organizations in successfully managing common business challenges such as:

* Optimizing product launches * Maximizing the impact of strategic alliances with marketing partners * Effectively managing competitive intelligence for strategic advantage * Maximizing share of mind with key opinion leaders * Synchronizing measurement and performance of global brand teams * Maximizing effectiveness between marketing, sales, and medical teams

To receive more information, please call (973) 889-1300 and ask for Business Development, or email knowledgesolutions@skila.com.

You can also visit Skila on the web at http://www.skila.com.

Skila

CONTACT: Todd Harrell, Skila, +1-973-889-1300 x222, toddharrell@skila.com

MORE ON THIS TOPIC